Antiretroviral nanoparticles: an extended drug delivery modality
- PMID: 22816141
- DOI: 10.4155/tde.10.42
Antiretroviral nanoparticles: an extended drug delivery modality
Abstract
The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous